Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Ram Navami 2024
Dubai Rains
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Drugs Control General Of India
FOLLOW
Drugs control general of india, Latest News
National :
Licenses of 18 pharma companies cancelled
By Shalini Bhardwaj New Delhi [India], April 13 : Licenses of 18 pharma compes have been cancelled for manufacturing ... ...
Health :
DCGI sends notice to e-pharmacies for selling drugs without licence
New Delhi, Feb 11 The Drugs Controller General of India (DCGI) has issued a showcause notice to online ... ...
National :
DCGI chief Dr V G Somani's term extended by 3 months
The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by ... ...
National :
Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster
Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI. ...
Health :
Corbevax gets DCGI nod as heterologous booster for adults
New Delhi, June 4 Hyderabad-based Pharmaceuticals firm Biological E Ltd (BE) on Saturday announced that its Covid-19 vaccine ... ...
National :
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials in 2-18 age group
Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said. ...
National :
Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI
Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources. ...
Health :
SEC recommends permission for Phase 3 trial of Covovax as booster
New Delhi, March 6 The Subject Expert Committee of India's apex drugs authority Drugs Controller General of India ... ...
Next Page